Steroids, Ltd.

2201 West Campbell Park Dr
Chicago, IL 60612
15 Employees

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $2.22MM
First Award Date 12/30/90
Most Recent Award Date 01/01/97

Key Personnel

Last Name Name Awards Contact
Rao Dr. Munagala S. Rao 1
Moriarty Robert M Moriarty 2
Liu Kaiming Liu 2
Guo Liang Guo 2
Penmasta Raju A Penmasta 1
Tuladhar Suddersan M. Tuladhar 1
Upadhyaya Subash Upadhyaya 1

10 Awards Won

Phase 1 SBIR

Agency: National Aeronautics and Space Administration
Topic: 97-1
Budget: 01/01/97 - 12/31/97

Phase 1 SBIR

Agency: National Aeronautics and Space Administration
Topic: 97-1
Budget: 01/01/97 - 12/31/97

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/95 - 09/30/95
PI: Liang Guo

Phase 2 SBIR

Agency: Air Force
Topic: AF93-091
Budget: 12/20/94 - 12/20/96

A pilot plant will be set up for the synthesis of multikilogram lots of 1,4-cubane decarboxylic acid (1,4-CDA). Five kilogram batches will be made with a cycle time of 11 to 12 weeks. In the initial 6 month period of the two year program the pilot plant will be constructed and 0.5 kg of 1,4 kg of 1,4-CDA will be made with existing equipment. ...

Phase 2 SBIR

Agency: Army
Topic: A92-162
Budget: 02/22/94 - 02/21/96

Haptens for the generation of catalytic monoclonal antibodies will be synthesized. Four categories will be pursued: the first is oxyphosphoranes for which promising immunogenic results have already been obtained by scientists at USAMRICD. The second is the synthesis of haptens for induction of specific catalogenic groups at the antibody bindi...

Phase 1 SBIR

Agency: Air Force
Topic: AF93-091
Budget: 06/30/93 - 12/31/93
PI: Liang Guo

Phase 1 SBIR

Agency: Army
Topic: A92-162
Budget: 02/16/93 - 08/15/93

Phase 1 SBIR

Agency: Missile Defense Agency
Topic: SDIO92-006
Budget: 07/15/92 - 01/15/93

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/16/92 - 12/31/92

Side-chain modified analogs of 1 alpha, 25-dihydroxyvitamin D3 have been shown to suppress proliferation of bone marrow myeloid cells as well as other leukemia cell lines, and effect differentiation both in vitro and in vivo of myeloid cells. These phenomena coupled with low calcemic activity offer promise for an anti-cancer drug which may block...

Phase 2 SBIR

Agency: Navy
Topic: N89-132
Budget: 12/30/90 - 12/30/92

BASED UPON RESULTS OBTAINED IN PHASE I, WE WILL SCALE UP THE SYNTHESES AND PROVIDE THIRTEEN NITRO-N-NITROSODIPHENYLAMINES, SEVENTEEN ETHYL CENTRALITIES, SEVENTEEN METHYL CENTRALITIES, NINETEEN NITRO-SUBSTITUTED DIPHENYLAMINES AND NINE NITRO-N-METHYL p-NITROANILINE DERIVATIVES. THESE COMPOUNDS WILL BE SYNTHESIZED IN 20 g LOTS. PURITY OF GREATER...

Load More